Table 2.
Laboratory parameters and radiologic features of 17 patients aged > 80 years with COVID-19.
| Characteristics | All patients (N = 17) |
Disease severity |
P value | |
|---|---|---|---|---|
| Non-severe (n = 8) | Severe (n = 9) | |||
| Laboratory examinations (median [IQR]) | ||||
| White blood cells (×109/L) | 7.0 (4.9–8.7) | 8.3 (7.3–9.5) | 5.0 (3.6–6.6) | 0.0206 |
| Lymphocytes (×109/L) | 1.0 (0.4–1.2) | 1.2 (0.9–1.4) | 0.4 (0.3–1.1) | 0.0141 |
| Hemoglobin level (g/L) | 113.0 (92.5–119.5) | 113.5 (97.3–124.3) | 113.0 (91.5–117.5) | 0.4946 |
| Platelet count (×109/L) | 157.0 (133.0–331.0) | 182.5 (145.5–241.8) | 152.0 (92.5–200.5) | 0.2460 |
| Alanine aminotransferase (U/L) | 13.0 (12.5–19.0) | 14.0 (11.5–25.3) | 13.0 (12.5–18.0) | 0.7571 |
| Aspartate aminotransferase (U/L) | 25.0 (18.5–31.5) | 21.5 (16.5–40.0) | 25.0 (22.0–30.0) | 0.7251 |
| Creatinine (μmol/L) | 76.0 (60–115) | 62.5 (52.8–85) | 99.0 (74.5–212.5) | 0.0377 |
| C-reaction protein (mg/L) | 14.3 (7.5–68.5) | 11.2 (5.9–74.8) | 28.3 (12.0–68.5) | 0.4234 |
| Serum amyloid A (mg/L) | 85.2 (42.1–210.7) | 51.7 (27.0–134.3) | 153.1 (73.55–227.7) | 0.0927 |
| Radiologic features (n [%]) | ||||
| Nodular foci | 10 (58.8) | 5 (62.5) | 5 (55.6) | 0.8826 |
| Pleural thickening | 7 (41.2) | 5 (62.5) | 2 (22.2) | 0.2761 |
| Fibrous cord | 5 (29.4) | 2 (25) | 3 (33.3) | 0.7805 |
| Ground-glass opacity | 2 (11.8) | 1 (12.5) | 1 (11.1) | 0.9372 |
| Pleural effusion | 2 (11.8) | 1 (12.5) | 1 (11.1) | 0.9372 |
COVID-19: coronavirus disease 2019; IQR: interquartile range. P values indicate differences between patients with severe and non-severe cases.